Clinical Trial Update: Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on quality of life outcomes for thyroid cancer patients treated with recombinant TSH (Thyrogen).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Thyrogen (thyrotropin alfa)

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Thyroid Cancer | Phase 4 | Status: COMPLETED